Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
October 30, 2013
Immunosignatures can predict vaccine efficacy
Joseph Barten Legutki, Stephen Albert Johnston
Experimental and Molecular Pathology
|
March 17, 2012
Autoreactive antibodies raised by self derived de novo peptides can identify unrelated antigens on protein microarrays. Are autoantibodies really autoantibodies?
Kaitlin Kroening, Stephen Albert Johnston, Joseph Barten Legutki
Clinical and Vaccine Immunology : CVI
|
January 13, 2012
Evaluation of biological sample preparation for immunosignature-based diagnostics
Brian Andrew Chase, Stephen Albert Johnston, Joseph Barten Legutki
BMC Cancer
|
September 10, 2014
The immunosignature of canine lymphoma: characterization and diagnostic application
Stephen Albert Johnston, Douglas H Thamm, Joseph Barten Legutki
Vaccine
|
May 11, 2010
A general method for characterization of humoral immunity induced by a vaccine or infection
Joseph Barten Legutki, D Mitchell Magee, Phillip Stafford, et al.
Expert Review of Vaccines
|
March 20, 2014
Could immunosignatures technology enable the development of a preventative cancer vaccine?
Luhui Shen, Debra Tumbula Hansen, Stephen Albert Johnston, et al.
Nature Communications
|
September 4, 2014
Scalable high-density peptide arrays for comprehensive health monitoring
Joseph Barten Legutki, Zhan-Gong Zhao, Matt Greving, et al.
Immunity & Ageing : I & A
|
October 12, 2020
Age-associated changes in the circulating human antibody repertoire are upregulated in autoimmunity
Aaron Arvey, Michael Rowe, Joseph Barten Legutki, et al.
Scientific Reports
|
December 16, 2017
A Simple Platform for the Rapid Development of Antimicrobials
Stephen Albert Johnston, Valeriy Domenyuk, Nidhi Gupta, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Proceedings of the National Academy of Sciences of the United States of America
|
October 30, 2013
Immunosignatures can predict vaccine efficacy
Joseph Barten Legutki, Stephen Albert Johnston
Experimental and Molecular Pathology
|
March 17, 2012
Autoreactive antibodies raised by self derived de novo peptides can identify unrelated antigens on protein microarrays. Are autoantibodies really autoantibodies?
Kaitlin Kroening, Stephen Albert Johnston, Joseph Barten Legutki
Clinical and Vaccine Immunology : CVI
|
January 13, 2012
Evaluation of biological sample preparation for immunosignature-based diagnostics
Brian Andrew Chase, Stephen Albert Johnston, Joseph Barten Legutki
BMC Cancer
|
September 10, 2014
The immunosignature of canine lymphoma: characterization and diagnostic application
Stephen Albert Johnston, Douglas H Thamm, Joseph Barten Legutki
Vaccine
|
May 11, 2010
A general method for characterization of humoral immunity induced by a vaccine or infection
Joseph Barten Legutki, D Mitchell Magee, Phillip Stafford, et al.
Expert Review of Vaccines
|
March 20, 2014
Could immunosignatures technology enable the development of a preventative cancer vaccine?
Luhui Shen, Debra Tumbula Hansen, Stephen Albert Johnston, et al.
Nature Communications
|
September 4, 2014
Scalable high-density peptide arrays for comprehensive health monitoring
Joseph Barten Legutki, Zhan-Gong Zhao, Matt Greving, et al.
Immunity & Ageing : I & A
|
October 12, 2020
Age-associated changes in the circulating human antibody repertoire are upregulated in autoimmunity
Aaron Arvey, Michael Rowe, Joseph Barten Legutki, et al.
Scientific Reports
|
December 16, 2017
A Simple Platform for the Rapid Development of Antimicrobials
Stephen Albert Johnston, Valeriy Domenyuk, Nidhi Gupta, et al.
Page
of 1